Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-07-2022 | Cervical Cancer | Case report

Anisodamine/irinotecan/nedaplatin

Lack of efficacy during treatment of locally advanced cervical cancer: case report

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Jiang Y, et al. Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis. Computational and Mathematical Methods in Medicine 2022: 2022. Available from: URL: http://doi.org/10.1155/2022/5936773 Jiang Y, et al. Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis. Computational and Mathematical Methods in Medicine 2022: 2022. Available from: URL: http://​doi.​org/​10.​1155/​2022/​5936773
Metadata
Title
Anisodamine/irinotecan/nedaplatin
Lack of efficacy during treatment of locally advanced cervical cancer: case report
Publication date
01-07-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-18639-0

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Heparin

Case report

Vancomycin